MATERIAL TRANSFER AGREEMENT
India

Date: [date].
Provider: [full legal name, constitution, registration number and address].
Recipient: [full legal name, constitution, registration number and address].

Material means the non-human research material, associated data and permitted progeny or derivatives described in Schedule 1. Research means the project described there. Investigator means the individual responsible for the Recipient's work.

This form is not an approval to transfer human material, clinical samples, pathogens, controlled substances, genetically modified organisms, biological resources subject to access-and-benefit-sharing requirements, or any item requiring a permit unless the relevant Schedule expressly identifies the item and every required approval has been obtained before transfer.

1. Transfer and permitted use
The Provider will supply the Material after the Conditions in Schedule 2 are satisfied. The Recipient may possess and use it only at the Approved Site, under the Investigator's supervision, for the non-clinical Research during the Research Period.

The Recipient must not administer the Material to a human, use it for diagnosis or treatment, release it into the environment, use it commercially, test it for unrelated purposes, reverse engineer it beyond the Research, or transfer it to another person without the Provider's written consent and all required approvals. Access is limited to trained personnel working on the Research who are bound by duties consistent with this Agreement.

2. Legal approvals and safety
Each party is responsible for licences and approvals applicable to its conduct. Before shipment, the parties must determine whether the Material or its source engages the Biological Diversity Act 2002, access and benefit-sharing rules, export or import controls, biosafety, animal, plant, environmental, health, customs or transport requirements. The Provider need not ship until Schedule 2 records the required approvals or confirms they do not apply.

The Recipient must follow the handling, containment, storage, security, transport and disposal controls in Schedule 2, applicable institutional policies and law. It must immediately stop work and notify the Provider of an unexpected hazard, contamination, loss, unauthorised access or regulatory concern.

3. Character and risk
The Provider will describe the Material and disclose known hazards in Schedule 1, but supplies it as experimental material without a promise of fitness, safety, purity or reproducibility except that the Provider has authority to transfer it. The Recipient accepts the scientific and operational risks and must conduct its own risk assessment.

The Recipient must not use the Provider's name to endorse a product or claim that the Provider validated the Research.

4. Ownership and limited right
The Provider retains ownership of the supplied Material. The Recipient owns modifications or inventions it creates only to the extent permitted by law and third-party rights, but the Provider retains rights in the original Material embodied in them. Progeny, unmodified derivatives and separated components remain treated as Material.

No patent, copyright, know-how or other intellectual-property licence is granted except the limited right to use the Material for the Research. If the Research produces a potentially protectable invention, the Recipient must notify the Provider confidentially before public disclosure. The parties will negotiate in good faith any additional rights needed for commercial development; neither is obliged to grant them.

5. Results and publication
The Recipient owns its Research results, subject to the Provider's rights in confidential information and Material. It must give the Provider a proposed publication at least [30] days before submission. The Provider may require removal of its confidential information and may request a delay of up to [60] additional days to file an intellectual-property application. The Provider may not suppress publication of valid results.

Authorship and acknowledgements must reflect actual contributions and accepted academic standards. The Recipient must not disclose the Provider's confidential information in a publication.

6. Confidentiality and data
Each party must protect confidential information received for the Research, use it only for this Agreement and disclose it only to authorised personnel. The duty does not cover information lawfully public, already known without restriction, independently developed or lawfully received elsewhere. Required disclosure is permitted after notice where lawful.

If associated data include personal data or sensitive regulated information, transfer may begin only after the parties document the lawful basis, permitted purpose, security, retention and any separate data terms in Schedule 2. The Recipient must not attempt to identify a person from coded or de-identified data.

7. Reports, incidents and records
The Recipient must keep records of receipt, inventory, access, use, storage, transfers and disposal for [five] years or the longer period law or an approval requires. It must provide the progress and final reports listed in Schedule 3 and promptly report a loss, misuse, accident or material non-compliance. The Provider may verify records and storage on reasonable notice without disrupting the Research unnecessarily.

8. End of use
This Agreement ends on the earlier of the end of the Research Period or termination. Either party may terminate for a material breach not cured within [10] days after notice; the Provider may require immediate suspension for a safety or legal risk.

At the end, the Recipient must follow the Provider's written choice to return or lawfully destroy remaining Material, and confirm completion within [30] days. Required archival records and permitted non-identifying results may be retained, protected by the surviving duties. Safety, confidentiality, ownership, publication, records and liability provisions survive as needed.

9. Liability and general
The Recipient is responsible for its handling and use of the Material. Each party is liable for loss caused by its breach, negligence or wilful misconduct, subject to [agreed limit]. No limit applies to fraud, wilful misconduct, unauthorised transfer or use, breach of confidentiality, death or personal injury caused by negligence, or liability that cannot lawfully be limited.

Neither party may assign without consent except to a successor that assumes the Agreement and can lawfully hold the Material. Notices take effect on proven receipt. Changes must be signed. Counterparts and valid electronic signatures may be used; applicable stamp and execution requirements must be satisfied.

Indian law governs. Courts at [city, State/Union Territory] have exclusive jurisdiction, subject to mandatory law.

SCHEDULE 1 - MATERIAL AND RESEARCH
Material, quantity, source, identifiers and known hazards: [details].
Research, Investigator, Approved Site and Research Period: [details].
Permitted progeny, derivatives and analytical methods: [details].

SCHEDULE 2 - APPROVALS AND CONTROLS
Biological Diversity Act/access-benefit-sharing assessment: [details].
Permits, ethics, biosafety, import/export and transport approvals: [details].
Containment, storage, security, disposal and emergency controls: [details].
Associated data and privacy terms: [details].

SCHEDULE 3 - DELIVERY AND REPORTING
Shipment, custody, costs and acceptance: [details].
Progress and final reports: [details].
Confidential and publication contacts: [details].
Notice details and liability limit: [details].

SIGNED
Provider: [name, position, signature and date].
Recipient: [name, position, signature and date].


---
License: Licensed under CC BY 4.0. Attribution is required when you publish or redistribute this Template or an adapted version to the public. Attribution is not required merely because you use or adapt the Template for your own business or legal purposes, including preparing, negotiating, signing, or exchanging an agreement with a counterparty. License details.
License details: https://contract-templates.getfebruary.ai/license/